| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 50,6 M € | +8.0% | 46,9 M € | +14.2% | 41,0 M € | +13.4% | 36,2 M € | +2.8% | 35,2 M € | +4.1% | 33,8 M € | +7.6% | 31,4 M € | +4.5% | 30,1 M € | +27.9% | 23,5 M € | +39.8% | 16,8 M € | -1.6% | 17,1 M € | -4.9% | 18,0 M € | +4.2% | 17,2 M € | -6.4% | 18,4 M € | +5.0% | 17,6 M € | -7.6% | 19,0 M € | -6.7% | 20,4 M € | +5.9% | 19,2 M € | +2.0% | 18,9 M € | +14.1% | 16,5 M € | |
| EBITDA | 1,8 M € | -31.1% | 2,6 M € | +36.4% | 1,9 M € | -5.8% | 2,1 M € | +135.1% | 873,8 k € | -49.7% | 1,7 M € | +16.3% | 1,5 M € | +254.0% | 422,3 k € | +2003.1% | -22,2 k € | -102.4% | 911,0 k € | +20.7% | 754,6 k € | -27.4% | 1,0 M € | +37.2% | 757,7 k € | -27.8% | 1,0 M € | +57.8% | 664,9 k € | -15.2% | 784,4 k € | -67.0% | 2,4 M € | +38.0% | 1,7 M € | -0.9% | 1,7 M € | +38.9% | 1,3 M € | |
| Operating profit | 723,2 k € | -66.5% | 2,2 M € | +58.4% | 1,4 M € | -19.1% | 1,7 M € | +90.7% | 884,3 k € | -43.1% | 1,6 M € | +30.1% | 1,2 M € | +181.9% | 423,3 k € | +371.7% | -155,8 k € | -120.1% | 773,2 k € | -15.3% | 913,4 k € | +3.7% | 880,7 k € | -18.7% | 1,1 M € | +86.3% | 581,6 k € | -17.2% | 702,8 k € | -31.9% | 1,0 M € | -46.3% | 1,9 M € | +9.9% | 1,7 M € | +2.5% | 1,7 M € | +40.3% | 1,2 M € | |
| Profit/loss | 234,0 k € | -83.0% | 1,4 M € | +74.2% | 787,9 k € | -21.5% | 1,0 M € | +145.7% | 408,5 k € | -57.7% | 965,4 k € | +50.9% | 639,9 k € | +605.5% | 90,7 k € | +143.7% | -207,4 k € | -143.5% | 477,4 k € | -16.6% | 572,6 k € | +1.6% | 563,8 k € | -17.9% | 686,5 k € | +93.9% | 354,1 k € | -21.3% | 450,0 k € | -32.5% | 666,4 k € | -47.7% | 1,3 M € | +8.4% | 1,2 M € | +3.6% | 1,1 M € | +40.5% | 806,9 k € | |
| Equity | 4,2 M € | 0.0% | 4,2 M € | 0.0% | 4,2 M € | 0.0% | 4,2 M € | -19.1% | 5,2 M € | 0.0% | 5,2 M € | 0.0% | 5,2 M € | -31.0% | 7,6 M € | +1.2% | 7,5 M € | +62.1% | 4,6 M € | +11.5% | 4,2 M € | +16.0% | 3,6 M € | +18.6% | 3,0 M € | +29.4% | 2,3 M € | +17.9% | 2,0 M € | -2.5% | 2,0 M € | -1.6% | 2,1 M € | +1.2% | 2,0 M € | -9.9% | 2,3 M € | +100.0% | 1,1 M € | |
| Total assets | 24,0 M € | +10.0% | 21,9 M € | +20.6% | 18,1 M € | +4.8% | 17,3 M € | -1.7% | 17,6 M € | +21.6% | 14,5 M € | -13.6% | 16,7 M € | -1.9% | 17,1 M € | +29.9% | 13,1 M € | +69.8% | 7,7 M € | +6.8% | 7,2 M € | -10.9% | 8,1 M € | +50.4% | 5,4 M € | -18.8% | 6,7 M € | +20.2% | 5,5 M € | -3.7% | 5,7 M € | +9.5% | 5,3 M € | +3.6% | 5,1 M € | +9.2% | 4,6 M € | +2.0% | 4,6 M € | |
| Cash | — | — | — | — | — | — | — | — | 1,0 k € | -100.0% | 2,1 M € | +2257.5% | 90,4 k € | -25.0% | 120,4 k € | -26.7% | 164,4 k € | -89.9% | 1,6 M € | +3.7% | 1,6 M € | +25.9% | 1,2 M € | +58.6% | 786,6 k € | -9.4% | 868,2 k € | +5.8% | 820,8 k € | +6.6% | 769,9 k € | |||||||||
| Debts | 18,8 M € | +13.0% | 16,6 M € | +29.3% | 12,9 M € | +5.2% | 12,2 M € | +6.4% | 11,5 M € | +34.1% | 8,6 M € | -21.5% | 10,9 M € | +41.0% | 7,7 M € | +51.6% | 5,1 M € | +65.1% | 3,1 M € | +0.5% | 3,1 M € | -32.1% | 4,5 M € | +90.7% | 2,4 M € | -44.8% | 4,3 M € | +21.6% | 3,6 M € | -4.4% | 3,7 M € | +16.7% | 3,2 M € | +5.2% | 3,0 M € | +27.4% | 2,4 M € | -30.5% | 3,4 M € | |
| Staff | 38,4 | 38,7 | 38,1 | 36,6 | 33,8 | 32,1 | 31,5 | 38,8 | 44,7 | 26,4 | 26,5 | 26 | 26,1 | 24,5 | 23,7 | 25,4 | 25 | 23,3 | 23,4 | 21,1 | ||||||||||||||||||||
Public limited company · Ixelles · incorporated on 08/10/1991 · 38,4 ETP
Public limited company profitable and well capitalised. Cash position declining (-100.0%).
Solid counterparty for a standard engagement.
Boehringer Ingelheim Animal Health Belgium SA is a Public limited company incorporated in 1991. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Ixelles. It employs on average 38,4 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette